• Aucun résultat trouvé

Generating biological models through gene transfer to domestic animals

N/A
N/A
Protected

Academic year: 2021

Partager "Generating biological models through gene transfer to domestic animals"

Copied!
6
0
0

Texte intégral

(1)

HAL Id: hal-02692132

https://hal.inrae.fr/hal-02692132

Submitted on 1 Jun 2020

HAL is a multi-disciplinary open access

archive for the deposit and dissemination of

sci-entific research documents, whether they are

pub-lished or not. The documents may come from

teaching and research institutions in France or

abroad, or from public or private research centers.

L’archive ouverte pluridisciplinaire HAL, est

destinée au dépôt et à la diffusion de documents

scientifiques de niveau recherche, publiés ou non,

émanant des établissements d’enseignement et de

recherche français ou étrangers, des laboratoires

publics ou privés.

Generating biological models through gene transfer to

domestic animals

Louis Houdebine

To cite this version:

(2)

Review

article

Generating biological

models

through

gene

transfer

to

domestic animals

LM

Houdebine

Unité de

différenciation

cellulaire, Inrn, 78352

Jouy-en-Josas

cedex, France

(Received

7

January

1997;

accepted

23

January

1997)

Summary ― Transgenic

domestic animals remain

infrequently

used as models for biochemical,

biomedical or

pharmaceutical

studies. The

difficulty

in

obtaining

these animals and the cost of their maintenance

explains

this situation. This review

briefly

summarizes the different

techniques

of gene

transfer,

targeted

or not, and also the

techniques

for

constructing

vectors for transgene

expression.

A few

examples

of domestic animal models are also

reported.

domestic animal /

transgenic

/ model

Résumé ― L’obtention de modèles

biologiques

par le transfert de

gène

à des animaux

domes-tiques.

Les animaux

domestiques transgéniques

sont encore peu utilisés comme modèles pour des

études fondamentales ou pour des

applications

biomédicales et

pharmaceutiques.

La difficulté d’obtention et le coût de ces animaux

expliquent

en

grande partie

cet état de fait. Cette revue fait le

point

sur les différentes

techniques

de transfert de

gène

ciblé ou non ainsi que sur les vecteurs

d’expression

des

transgènes. Quelques exemples

de modèles animaux

exploités

sont

également

rap-portés.

animal

domestique

/

transgénique

/ modèle

INTRODUCTION

About 15 years ago,

pioneering

experiments

demonstrated the

possibility

of gene

trans-fer into animals

resulting

in transmission to

their progeny as well as

expression

of the

foreign

DNA

(Gordon

et

al, 1980;

Palmiter

et

al, 1982).

This

opened

new avenues for

basic studies into gene function and for

mul-tiple

applications

in medicine and

agricul-ture. New animal models have been created

using

gene transfer and gene inactivation

mainly

with mice

(Lathe

and

Mullins, 1993).

There are several

practical

reasons for which

(3)

mice have been used

extensively

to

generate

animal models for the

study

of diseases.

Gene transfer is

relatively

efficient in this

species.

Gene inactivation

by homologous

recombination has

only

been achieved in the mouse, and

finally,

mice can be raised and maintained

relatively inexpensively.

The mouse,

however,

is not

always

an

appropriate

model. It is too small to be used

easily

for

surgical operations.

It is also too

different from humans in some

biological

functions. The use of other

species,

and

par-ticularly

domestic

animals,

is considered

highly

desirable. For technical and finan-cial reasons, this remains limited to a small number of

situations.

In this

review,

the dif-ferent

techniques

of gene transfer into

ani-mals and a few

examples

of domestic animal

models are described. Two other reviews

on the same

subject

have also been

pub-lished

recently

(Petters, 1994;

Mullins and

Mullins, 1996).

TECHNIQUES

OF GENE

TRANSFER TO ANIMALS Addition of a

foreign

gene

The addition of a

foreign

gene to a genome

is

theoretically

the

simplest

experimental

modification of the genome. To create lines of

genetically

modified

animals,

gene

trans-fer must be achieved in the

early embryo.

The transfection

techniques

used to

trans-fer genes into cultured cells are not

suffi-ciently

efficient to be used for

embryos.

More

sophisticated

methods must therefore be used in most cases. The direct

microin-jection

of isolated genes into one of the

pronuclei

of mammalian

embryos

is the

most

commonly

used

technique. Up

to five

transgenic

mice can be obtained in this way

from 100 one-cell

embryos.

The resultant

yield

is also

high

in the rabbit but is

quite

variable in other mammals. The cost of founder

transgenics

is thus

high

in

large

domestic animals

(Gagne

et

a], 1997).

In

ruminants and

especially

in cows, one-cell

embryos

can be obtained from

oocytes

col-lected in the

slaughterhouse

after in vitro maturation and fertilization

(Crozet, 1997).

The cost of

generating

the

embryos

is thus

highly

reduced. After gene

microinjection,

the

embryo

can

develop

in vitro until the

blastocyst

stage

when it is transferred into the uterus. This allows the

spontaneous

elim-ination of

embryos

which do not survive after

microinjection

and

possibly

the selec-tion of those which harbour the

foreign

gene

(Thompson

et

al, 1995).

This

approach

has the

advantage

of

considerably reducing

the number of

recipient

females and therefore the cost of the

transgenic

founders.

In lower vertebrates and invertebrates

injection

into the

cytoplasm

of

embryos

may

generate

transgenic

animals

(Devlin,

1997).

Use of viral vectors

Defective viral genomes can transfer

for-eign

genes into

embryos.

This is

particu-larly

the case for retroviral vectors

(Ronfort

et

al, I 997).

These vectors have a

specific

or

amphotropic envelope

and show limited

efficiency. They

are

only

used in birds and

invertebrates.

Somewhat

unexpectedly,

recent

experi-ments have shown that

non-replicative

ade-noviral vectors

integrate

into the mouse

embryo

genome with considerable

effi-ciency (Tsukui et

al,

1996).

Use of

embryonic

cells

Totipotent embryonic

stem cells

(ES cells)

can be cultured for

long periods

of time and

participate

in the

development

of chimaeric

embryos

after

having

been

injected

into the

embryos

at the morula or the

blastocyst

stage.

Gene transfer can be carried out in these

(4)

trans-fection methods.

Multiple sophisticated

vec-tors make it

possible

to select the

totipotent

cells which have

integrated

the gene

through

an

homologous

recombination process. This

allows

specific

gene knock-out or

replace-ment (Viville, 1997).

In

practice, totipotent

cells can

only

be

used in the mouse. Recent

experiments

indi-cate

that totipotent

cells have been obtained

in the

pig

(Anderson, 1996)

and chicken

(Pain

et

al, 1996).

Interestingly,

sheep multipotent

cells lines

incapable

of

participating

in the

generation

of chimaeric

embryos

can result in the birth of normal lambs after

being

introduced into

enucleated

oocytes

(Campbell

et

a], 1996).

This

experiment

offers

quite interesting

pos-sibilities if the

techniques

can be

improved

and extended to other

species

and if

foreign

genes can be introduced into these cells for gene

targeting

or for

simple transgenesis.

Spermatozoa

precursors are also

potential

vectors for

foreign

gene transfer. In vitro fertilization can be achieved with immature

spermatozoa

using

microinjection

into

oocytes.

Mice testes can also be colonized

with immature

spermatozoa

from other

mice,

rats and

potentially

other

species.

These

spermatozoa

then become

fully

func-tional

(Clouthier et al, 1996).

Conventional

or

targeted

gene transfer could be carried

out

during

the culture of the

spermatozoa

precursor.

Although promising,

these

tech-niques

cannot be used at

present

for gene

transfer.

Improvement

of cell culture

tech-niques

is

required

before it becomes

possi-ble.

VECTORS FOR TRANSGENE EXPRESSION

Gene transfer

by

transfection or

microin-jection

leads to uncontrolled

integration

and

to an

unpredictable

level of

transgene

expression.

Gene insulators that allow a

high

and copy number

dependent expression

of

transgenes

have been identified

(Sippel

et

at,

1997).

Full characterization of these insu-lators is still

required

before their use can

be

generalized.

In some cases,

large genomic

DNA

fragments

contain insulators

(Umland

et al, I 997).

Gene knock-out is not the

only

way to

specifically

inactivate gene

expression.

Anti-sense RNA and

ribozymes

can reduce or

inhibit the

synthesis

of a

protein by

inacti-vating

its mRNA

(Carmichael, 1997;

Han

and

Wagner,

1997).

Overexpression

of

mutated genes

coding

for

proteins having

dominant

negative

effects can also be used

successfully

in some cases

(Chang

et

ai,

1994).

Non-secreted antibodies

(intrabod-ies)

may also act

efficiently

to inactivate cellular

proteins

(Jones

and

Marasco, 1997).

Promoters reconstituted

by

genetic

engi-neering

can be sensitive to inducers

having

no effect on host genes. These inducers can

switch

transgenes

on and off in a

specific

and

potent

manner.

Tetracycline-sensitive

promoters

are among those which have met

with

impressive

success

(Kistner

et

at,

1996).

Quite

specific

and efficient recombina-tions can be induced at

specific

DNA sites

by foreign

recombinases. The most

fre-quently

used

system

is based on the

utiliza-tion of a lox DNA sequence and on the Cre recombinase from the E coli

P !

phage.

The

Cre recombinase

triggers

a recombination

of the lox sequences which may be intro-duced into known sites on gene constructs or on genomes. This recombination may lead to

the

specific

inactivation of a gene if it

gen-erates a deletion within the gene. It may activate a

promoter

as well

by removing

an

inhibitory

DNA

fragment.

It may also lead

to

homologous

recombination and the

tar-geted

knock-out of a

given

cell

type

at a

given

stage

in its differentiation. This

(5)

promoter

specifically

active in this cell

(Kuhn et al, 1995).

There are many other

possible

combina-tions of these tools which result in a

rea-sonably satisfactory

control of

transgene

expression.

TRANSGENIC DOMESTIC ANIMAL MODELS

Apart

from the mouse, the rabbit is

probably

y the most

frequently

used

species

as an

ani-mal model. Rabbits are as sensitive to

atherosclerosis as humans. Human

apolipoprotein

genes have been transferred

to rabbits

(Duverger

et

al,

1996;

Mc

Cormick et

al, 1997).

These animals arc more resistant or sensitive to

cholesterol-rich diets than control rabbits

depending

on

the

particular

genes transferred.

They

are

good

models for

studying

the process of

atherosclerosis,

for

evaluating

the

efficiency

of the

drugs

that stimulate the

expression

of the genes

coding

for

high density

lipopro-teins and for

testing

gene constructs that may be used in gene

therapy.

Moreover,

these

transgenic

rabbits may be crossed with the Watanabe line which is devoid of low

density lipoprotein

(LDL)

receptors

and so

may

provide interesting

information

con-cerning

the effect of

apolipoproteins

on

atherosclerosis.

Rabbit cells can

generate

Human

Immunodeficiency

Virus

(HIV)

particles

when transfected with the viral genome.

Transgenic

rabbits

expressing

the human CD4 gene can be infected with HIV. These

animals did not go on to

develop

AIDS but

they

may be

good

models to evaluate the

efficiency

of a vaccine

(Dunn

et

al, 1995).

The use of

pig

organs for

transplantation

to humans is

becoming increasingly

neces-sary. The

study

of the

hyperacute

rejection

of pig

organs can be carried out with

trans-genic pigs expressing

various

foreign genes.

The organs from

pigs

expressing

human

DAF or CD59 genes are

rejected

much more

slowly

than those from control animals

(Cozzi

and

White,

1995).

The number

of transgenic

domestic

ani-mals raised and used as models for

biolog-ical,

biomedical or

pharmaceutical

studies is

still very low

although

their use is

easily

justified.

This is

largely

due to the technical difficulties involved and the cost of

obtain-ing

these animals. Substantial progress is

being

made on the

manipulation

of

embryos

and

embryonic

stem

cells,

and ttlso on the

construction of efficient vectors for

trans-gene

expression.

The

generation

of domes-tic

transgenic

animals should therefore

become more feasible in the

coming

years.

It should be

kept

in

mind, however,

that

generation

and

breeding

of

large transgenic

animals will remain a

relatively demanding

task. This

implies

that the animals lines used for

transgenesis

be chosen

carefully.

Indeed,

the

genetic background

of the animals may

have

quite

a

significant

impact

on the effects

of the

transgene

and

impair

the

validity

of

the models

(Carvallo

et

at, 1997).

REFERENCES

Anderson GB (1996) Molecular aspects qf’ embryo

development. Arquivos de Faculdidc de Veteri-naria UFRGS, Porto Alegre, Portugal, Suplemento 24. 184-190

Campbcll KHS, McWhir J. Ritchie WA, Wilmut I

( 1996) Sheep cloned by nuclear transfer from a

cultured cell line. Nature 380, 64-66

Carinichael GG ( 1997) Nuclear antiscnsc RNA as a

tool to inhibit gene expression. In: Tra1l.B’lienic

Ani-mal: Generation and Use. (LM Houdebine ed),

Harwood Academic Publishers, Amsterdam, the Netherlands, 327-330

Carvallo D, Canard G, Tucker D ( 1997 ) Standardiza tion of transgenic lines: from founder to an estab-lishcd animal model. In: Transgenic Anilllal: Gen-eration cand U,re. (LM Houdcbinc cd), Harwood Academic Publishers, Amsterdam, the Netherlands, 403-410 0

C h

ang PY. Benecke H, Le Marchand-Brustcl Y, Lawitls J. Mollcr DE ( 1994) Expression of a

(6)

Clouthict- Dli, Avarhock MR, Maika SD, Hanuncr RIO, i, Brinster RL ( 1996) Rat spermatogenesis in mouse

testis. Nature 381, 418 8

Cozzi E, White DJG (1995) The generation of

trans-genic pigs as potential organ donors for humans.

Nature Medicine 1, 964-966

Crozct N ( 1997) In vitro generation of one cell embryos

in sheep and goat. In: TrW1S!inJic !/7/m!/.’ Cener-ation and U.se. (LM Houdebine ed), Harwood Aca-demic Publishers Amsterdam, the Netherlands, 45-50

Devlin DH ( 1997) Transgenic salmonids In:

Trans-genic Animal: Generation and Use. (LM Houdebine

ed), Harwood Academic Publishers Amsterdam, the Netherlands, 1 !l5- 1 1 8

Dunn CS, Mehtali M, Houdebine LM, Gut JP, Kirn A, Aubertiii AM (1995) Human immunodeficiency virus type I infection of human CD4 transgenic rabbits. J Gen Virol76, 1327-1336

Duvcrger N, Kruth H, Emmanucl F, Caillaud JM, Vigli-etta C, Castro G, Tailleux A, Fievet C, Fruchart JC, Houdcbine LM, Denetle P (1996) Inhibition of athcrosclerosis development in cholesterol-fed human apotipoprotein A-1-transgenic rabbits. Cir-cu

k

rtinn 94, 713-717 7

Gagn6 M, Pothicr F, Sirard MA ( 1997) Gene

microin-jection into bovine pronuclei. In: Transf?e/lic Ani-mal.! Cf<!(Yaf;on and Use. (LM Houdebine ed), Harwood Academic Publishers Amsterdam, the Netherlands, 27-36

Gordon JW, Scangos GA, Plotkin DJ, Barbosa JA, Ruddle FH ( 1980) Genetic transformation of mousc

embryos by microinjection of purified DNA. Prno Natl Acad Sci USA 77, 7380-7384

Han L, Wagner TA (1997) The use of antisense RNA and ribozyme sequences to prevent infectious

dis-eases in transgenic animals. In: Transgenic Ani-mals: Generation and U.se. (LM Houdebine ed), Harwood Academic Publishers Amsterdam, the Netherlands, 489-494

Jones SD, Marasco WA (1997) Intracellular antibodies

(intrabodies): potential applications in transgenic animal research and engineered resistance to

pathogens. In: Transgenic Animals: Generation nnd U.se. (LM Houdcbine ed), Harwood Academic Publishers Amsterdam, the Netherlands, 501-506 Kistner A, Gossen M, Zimmennann F, Jerecic J, Ulhner C, Ldbbert H, Bujard H ( 1996) Doxycycline-medi-ated quantitative and tissue-specific control of gene

expression in transgenic mice. Proc Natl Acad Sci

USA 93, 10933-10938

Kiihn R, Schwenk F, Aguet M. Rajewsky K (1995) Inducible gene targeting in mice. Science 269, 1427-1429

Lathe R, Mullins JJ ( 1993) Tranagcnic animals as mod-els for human disease. Report of an EC study group.

Transgeni, Res 2, 286-299

McCormick SPA, Allan CM, Taylor JM, Young SG

(1997) The use of P1 bacteriophagc clones to

gen-erate transgenic animals. In: Transgenic Animal: Generutian and U.se. (LM Houdebine ed), Har-wood Academic Publishers Amsterdam, the Nether-lands, 273-282

Mullins LJ, Mullins JJ (1996) Molecular medicine in

genetically engineered animals. Transgenesis in the rat and larger mamiyials../ Cliii Iiiv,est 97,

1557-1560

Pain B, Clark ME, Shen M, Nakazawa H, Sakurai M, Samarut J. Etches RJ (1996) Long-term in vitro culture and characterisation of avian embryonic

stem cells with multiple morphogenetic potential-ities. DevelofJment 122, 2339-2348

Palmiter RD, Briiistei- RL, Hammer RE, Trumbauer ME, Roscnfcld MG, Birnbcrg NC, Evans RM

( 1982) Dramatic growth of micc that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Naturr 300, 61 I-615 5 Pettcrs RM ( 1994) Transgenic livestock as genetic

models of human disease. Reprod h’ertil Deu 6, 643-645

Ronfort CM. Legras C, Verdier G ( 1997) The use of retroviral vectors for gene transfer into bird embryo.

In: 7’m;!.t!p);;(’!;)/n:a/.’ Cfo!mh’nn and Use. (LM

Houdebine ed), Harwood Academic Publishers Amsterdam, the Netherlands, 83-94

Sippel AE, Saucressig H, Hubler MC, Faust N, Bonifer C ( 1997) Insulation of transgencs from chromoso-mal position effects. In: 7’m<!.!’p;;;c /l/)t/)M/. Gen-er-ntion ond U.se. (LM Houdebine ed), Harwood Academic Publishers Amsterdam, the Netherlands, 257-266

Thompson EM, Adenot P, Tsuj i FI, Renard JP ( 1995)

Real time imaging oftranscriptional activity in live

mouse preimplantation embryos using a secreted luciferiise. l’roc Natl Acad Soi USA 92, 1317-1321 1 Tsukui T, Kancgac Y, Saito I, Toyoda Y (1996)

Trans-genesis by adenovirus-mediaued gene transfer into

mouse zona-free eggs. Nature Biotechnololy 14,

982-985

Umland T, Montoliu L, Schutz G (1997) The use of yeast artificial chromosomes for transgenesis. In:

Transgenic Animal: Geiiertiiioii and Use. (LM Houdebine ed), Harwood Academic Publishers Amsterdam, the Netherlands, 289-298

Vivillc S (1997) Mouse genetic manipulation via

homologous recombinaison. In: Transgenic Ani-mnl: Generation and Use. (LM Houdebine ed),

Références

Documents relatifs

We show that there exists a natural construction of random directed animals on any directed graph together with a particle system that explains at the level of objects the formal

The primary reason for using a mucosal route of immunization is that most infec- tions affect or initiate the infectious process at the mucosal surfaces, and that in these

of individual metaphase chromosomes, by analysis of subchromosomal fragments using somatic cell genetics and/or genomic or gene sequencing by molecular

Based on an adapted clustering procedure of microarray expression data used in conjunction with an automated annotation procedure, FunCluster identifies relevant GO categories

Used for 3D induction of follicles with the incorporation of the whole derma papillae or cultured papilla cells into the skin equivalent Study of chemical that may facilitate

Rozenn Dalbies-Tran, Maud Peyny, Peggy Jarrier-Gaillard, Véronique Cadoret, Laurent Boulanger, Nathalie Daniel, Véronique Duranthon,..

In this paper, we have presented a process to transform an UML/OCL model composed of class diagrams and OCL constraints into a FoCaLiZe specification. A Fo- CaLiZe species is

Dans notre premier chapitre, nous présenterons l’évolution des filières agroalimentaires dans le monde ainsi que l’évolution de la production de chaque filière ; nous aborderons